HY Director Adds 948 Shares via Equity Grant 鈥� Form 4 Filing

Q: How many Hyster-Yale (HY) shares did the director acquire?

Carolyn Corvi received 948 Class A common shares as an equity award.

Q: What is Carolyn Corvi鈥檚 total HY share ownership after the transaction?

She now holds 25,222 Class A common shares directly.

Q: Was this an open-market purchase or a compensation grant?

It was an equity award (transaction code 鈥淎鈥�) under the Non-Employee Directors鈥� Equity Compensation Plan.

Q: Does the filing include any derivative securities transactions?

No, Table II shows no derivative securities acquired or disposed of.

[Form 4] Hyster-Yale, Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Hyster-Yale, Inc. (HY) 鈥� Form 4 insider filing dated 07/01/2025

Director Carolyn Corvi received 948 Class A common shares under the company鈥檚 Non-Employee Directors鈥� Equity Compensation Plan at a stated price of $0 per share. The award lifts her direct ownership to 25,222 shares. No derivative securities were involved and the filing lists the transaction code 鈥淎鈥� (award/grant). Because the shares were granted, not purchased on the open market, the filing primarily reflects routine director compensation rather than an active investment decision.

Reporting person: Carolyn Corvi, outside director
Transaction type: Equity award (鈥淎鈥� code)
Transaction date: 07/01/2025
Total shares now owned directly: 25,222
Indicates continued board-level equity alignment but minimal financial impact to HY

Positive

Director ownership increases by 948 shares, reinforcing alignment with shareholder interests.

Negative

Grant, not open-market purchase, so provides limited insight into insider conviction and has negligible market impact.

Insights

TL;DR: Routine equity grant; negligible market impact; modestly positive alignment signal.

The Form 4 shows a standard annual grant of 948 shares to Director Carolyn Corvi under the Non-Employee Directors鈥� Equity Compensation Plan. Because the shares were awarded at no cost, cash outlay is zero and there is no direct demand signal from the director. The increase brings her stake to 25,222 shares, which is immaterial relative to HY鈥檚 ~16 million share float but keeps board members economically aligned with shareholders. As it neither represents an open-market purchase nor a sale, the disclosure is neutral-to-slightly-positive for sentiment and has no material impact on valuation or liquidity.

07/02/2025 - 02:01 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Corvi Carolyn

(Last)

(First)

(Middle)

5875 LANDERBROOK DRIVE

(Street)

MAYFIELD HEIGHTS

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
HYSTER-YALE, INC. [ HY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	07/01/2025		A⁽¹⁾		948	A	$0	25,222	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Award-Shares of Class A Common Stock awarded to the Reporting Person as "Required Shares" under the company's Non-Employee Directors' Equity Compensation Plan.

	/s/ Suzanne S. Taylor, attorney-in-fact	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many Hyster-Yale (HY) shares did the director acquire?

Carolyn Corvi received 948 Class A common shares as an equity award.

What was the transaction price for the awarded shares?

The shares were granted at $0 per share under the directors鈥� compensation plan.

What is Carolyn Corvi鈥檚 total HY share ownership after the transaction?

She now holds 25,222 Class A common shares directly.

Was this an open-market purchase or a compensation grant?

It was an equity award (transaction code 鈥淎鈥�) under the Non-Employee Directors鈥� Equity Compensation Plan.

Does the filing include any derivative securities transactions?

No, Table II shows no derivative securities acquired or disposed of.

AG真人官方

[Form 4] Hyster-Yale, Inc. Insider Trading Activity

Insights

FAQ

How many Hyster-Yale (HY) shares did the director acquire?

What was the transaction price for the awarded shares?

What is Carolyn Corvi鈥檚 total HY share ownership after the transaction?

Was this an open-market purchase or a compensation grant?

Does the filing include any derivative securities transactions?

NYSE:HY

HY Rankings

HY Latest News

HY Latest SEC Filings

HY Stock Data

AG真人官方

Trending News

[Form 4] Hyster-Yale, Inc. Insider Trading Activity

Insights

Financial Analyst neutral

FAQ

How many Hyster-Yale (HY) shares did the director acquire?

What was the transaction price for the awarded shares?

What is Carolyn Corvi鈥檚 total HY share ownership after the transaction?

Was this an open-market purchase or a compensation grant?

Does the filing include any derivative securities transactions?

NYSE:HY

HY Rankings

HY Latest News

HY Latest SEC Filings

HY Stock Data